TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year TCTMD By LA McKeown SAN FRANCISO, CA—New-generation zotarolimus-eluting stents are noninferior to everolimus-eluting stents at 1 year in patients with stable angina or non-ST-segment elevation acute coronary syndromes (ACS), according to the results of a ... |
